Phase I study of chemokine and cytokine gene-modified autologous neuroblastoma cells for treatment of relapsed/refractory neuroblastoma using an adenoviral vector

Hum Gene Ther. 2000 Jul 1;11(10):1477-88. doi: 10.1089/10430340050057549.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I

MeSH terms

  • Adenoviridae / genetics*
  • Adolescent
  • Adult
  • Chemokines, C*
  • Child
  • Child, Preschool
  • Female
  • Gene Transfer Techniques
  • Genetic Therapy*
  • Humans
  • Immunotherapy*
  • Infant
  • Interleukin-2 / genetics*
  • Lymphokines / genetics*
  • Male
  • Neuroblastoma / genetics*
  • Neuroblastoma / therapy*
  • Recurrence
  • Sialoglycoproteins / genetics*
  • Transduction, Genetic
  • Tumor Cells, Cultured

Substances

  • Chemokines, C
  • Interleukin-2
  • Lymphokines
  • Sialoglycoproteins
  • XCL1 protein, human
  • lymphotactin